Immunome (IMNM) EPS (Basic) (2019 - 2026)

Immunome's (IMNM) quarterly EPS (Basic) came in at -$2.16 in Q1 2026, down 281.82% YoY from $1.19 in Q1 2025, and down 158.8% on a QoQ basis from -$0.83 in Q4 2025.

Immunome (IMNM) EPS (Basic) (2019 - 2026) Analysis & Trends

Immunome (IMNM) has 8 years of EPS (Basic) data on file, last reported at -$2.16 in Q1 2026.

  • Quarterly EPS (Basic) fell 281.82% year-over-year to -$2.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.33 (down 3.91% YoY) and the FY2025 annual result came in at -$4.63, up 34.13% from the prior year.
  • EPS (Basic) declined to -$2.16 in Q1 2026, from -$0.83 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.36 in Q3 2023 to a low of -$4.67 in Q4 2023.
  • A 5-year average of -$1.34 and a median of -$0.97 in 2022 frame the typical range for EPS (Basic).
  • Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 627.06% — and 2025, when it jumped 77.99%.
  • Tracing IMNM's EPS (Basic) over 5 years: stood at -$0.64 in 2022, then plunged by 627.06% to -$4.67 in 2023, then soared by 69.58% to -$1.42 in 2024, then soared by 41.26% to -$0.83 in 2025, then plunged by 158.8% to -$2.16 in 2026.
  • The last three EPS (Basic) figures came in at -$2.16 (Q1 2026), -$0.83 (Q4 2025), and -$1.16 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.62
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.59
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.18
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.23
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Immunome 3.09 Bn 2.57 Bn - -2.19

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.19
Mar 31, 2026 -2.16
Dec 31, 2025 -0.83
Sep 30, 2025 -1.16
Jun 30, 2025 -0.81
Mar 31, 2025 -0.57
Dec 31, 2024 -1.42
Sep 30, 2024 -1.93
Jun 30, 2024 -1.44
Mar 31, 2024 -2.57
Dec 31, 2023 -4.67
Sep 30, 2023 -0.36
Jun 30, 2023 -1.32
Mar 31, 2023 -0.38
Dec 31, 2022 -0.64
Sep 30, 2022 -0.75
Jun 30, 2022 -0.88
Mar 31, 2022 -0.97
Dec 31, 2021 -0.68
Sep 30, 2021 -0.65